Johnson and Johnson to offer first TB drug in 40 years for $900 Industry-The Economic Times — July 22, 2018 comments off J&J said India is eligible for the lowest global price and that it is working on a sustainable access strategy.
J&J said India is eligible for the lowest global price and that it is working on a sustainable access strategy.